Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$5.02 - $7.05 $22,690 - $31,866
-4,520 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$4.81 - $10.34 $7,864 - $16,905
1,635 Added 56.67%
4,520 $26,000
Q4 2020

Jan 13, 2021

SELL
$4.13 - $6.41 $2,746 - $4,262
-665 Reduced 18.73%
2,885 $14,000
Q3 2020

Nov 12, 2020

SELL
$4.82 - $7.72 $1,735 - $2,779
-360 Reduced 9.21%
3,550 $21,000
Q2 2020

Aug 13, 2020

BUY
$5.69 - $9.69 $3,983 - $6,783
700 Added 21.81%
3,910 $26,000
Q4 2019

Feb 07, 2020

BUY
$3.0 - $16.43 $7,635 - $41,814
2,545 Added 382.71%
3,210 $33,000
Q3 2019

Nov 14, 2019

BUY
$3.93 - $15.35 $2,613 - $10,207
665 New
665 $3,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.